Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University Medical Center Goettingen
Information provided by:
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
ClinicalTrials.gov Identifier:
NCT01355913
First received: May 17, 2011
Last updated: August 7, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2019
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)
No publications provided by Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):